Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


Articles published in Semin Radiat Oncol

Retrieve available abstracts of 8 articles:
HTML format
Text format



Single Articles


    April 2018
  1. OJERHOLM E, Bekelman JE
    Finding Value for Protons: The Case of Prostate Cancer?
    Semin Radiat Oncol. 2018;28:131-137.
    PubMed     Text format     Abstract available


    July 2017
  2. KISHAN AU, King CR
    Stereotactic Body Radiotherapy for Low- and Intermediate-Risk Prostate Cancer.
    Semin Radiat Oncol. 2017;27:268-278.
    PubMed     Text format     Abstract available


    January 2017
  3. BROUGHMAN JR, Chen RC
    Management of Node-Positive and Oligometastatic Prostate Cancer.
    Semin Radiat Oncol. 2017;27:79-86.
    PubMed     Text format     Abstract available


  4. TETREAULT-LAFLAMME A, Crook J
    Options for Salvage of Radiation Failures for Prostate Cancer.
    Semin Radiat Oncol. 2017;27:67-78.
    PubMed     Text format     Abstract available


  5. NGUYEN PL
    Optimization of the Radiation Management of High-Risk Prostate Cancer.
    Semin Radiat Oncol. 2017;27:43-49.
    PubMed     Text format     Abstract available


  6. REBBECK TR
    Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography.
    Semin Radiat Oncol. 2017;27:3-10.
    PubMed     Text format     Abstract available


  7. MOGHANAKI D, Turkbey B, Vapiwala N, Ehdaie B, et al
    Advances in Prostate Cancer Magnetic Resonance Imaging and Positron Emission Tomography-Computed Tomography for Staging and Radiotherapy Treatment Planning.
    Semin Radiat Oncol. 2017;27:21-33.
    PubMed     Text format     Abstract available


  8. HALL WA, Lawton CA, Jani AB, Pollack A, et al
    Biomarkers of Outcome in Patients With Localized Prostate Cancer Treated With Radiotherapy.
    Semin Radiat Oncol. 2017;27:11-20.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: